INDP · Categories · Form 4
INDP - SEC Form 4 insider transactions
Indaptus Therapeutics Inc. (INDP) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for INDP
- SEC Form 4 filed by Lazar David E.4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4 filed by Director Jabbour Jerome D4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4 filed by Co-Chief Executive Officer Meckler Jeffrey A4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- Director Ben-Tzvi Avraham was granted 25,000 shares, increasing direct ownership by 25,000% to 25,100 units (SEC Form 4)4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4 filed by Director Natan David4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- Chief Operating Officer Linscott Walt Addison was granted 54,421 shares, increasing direct ownership by 1,088,420% to 54,426 units (SEC Form 4)4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- Co-Chief Executive Officer Meckler Jeffrey A was granted 216,617 shares, increasing direct ownership by 1,627% to 229,929 units (SEC Form 4)4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- Chief Financial Officer Sassi Nir was granted 26,758 shares (SEC Form 4)4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- CSO and Director Newman Michael James was granted 52,204 shares, increasing direct ownership by 107% to 101,074 units (SEC Form 4)4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- Chief Executive Officer Meckler Jeffrey A was granted 6,068 shares, increasing direct ownership by 84% to 13,312 units (SEC Form 4)4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4 filed by Director Karah Hila4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4 filed by Director Martell Robert4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4 filed by Director Pomerantz Roger4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4 filed by Director Hayes William B4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4 filed by Director Maddaluna Anthony J4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4 filed by Director Gilbert Mark John4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- CEO and Director Meckler Jeffrey A was granted 42,553 shares, increasing direct ownership by 27% to 202,859 units (SEC Form 4)4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4 filed by CEO and Director Meckler Jeffrey A4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4 filed by Chief Operating Officer Linscott Walt Addison4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4 filed by CSO and Director Newman Michael James4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Waltzman Roger J.4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Sassi Nir4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- CEO and Director Meckler Jeffrey A was granted 84,932 shares, increasing direct ownership by 113% to 160,306 units (SEC Form 4)4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4 filed by Pomerantz Roger4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4 filed by Karah Hila4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4 filed by Maddaluna Anthony J4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4 filed by Gilbert Mark John4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4 filed by Martell Robert4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4 filed by Hayes William B4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4 filed by Newman Michael James4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4 filed by Waltzman Roger J.4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4 filed by Linscott Walt Addison4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4 filed by Meckler Jeffrey A4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4 filed by Sassi Nir4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4: Anderson Glen R. bought $216,388 worth of shares (103,352 units at $2.09)4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4 filed by Waltzman Roger J.4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4 filed by Karah Hila4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4 filed by Hayes William B4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4 filed by Gilbert Mark John4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4 filed by Pomerantz Roger4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4 filed by Maddaluna Anthony J4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4 filed by Martell Robert4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4 filed by Linscott Walt Addison4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4 filed by Meckler Jeffrey A4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4 filed by Newman Michael James4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4 filed by Sassi Nir4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4: Litchev Boyan Vesselinov bought $2,520 worth of shares (1,150 units at $2.19)4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4: Meckler Jeffrey A bought $18,945 worth of shares (10,000 units at $1.89), increasing direct ownership by 15% to 75,374 units4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4 filed by Karah Hila4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4 filed by Pomerantz Roger4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4 filed by Hayes William B4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4 filed by Maddaluna Anthony J4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4 filed by O'Callaghan Brian4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4 filed by Gilbert Mark John4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4: Meckler Jeffrey A bought $28,862 worth of shares (10,308 units at $2.80), increasing direct ownership by 19% to 65,374 units4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4: Linscott Walt Addison bought $393 worth of shares (150 units at $2.62)4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4: Meckler Jeffrey A bought $24,771 worth of shares (9,692 units at $2.56), increasing direct ownership by 21% to 55,066 units4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4: Meckler Jeffrey A bought $51,882 worth of shares (19,727 units at $2.63), increasing direct ownership by 77% to 45,374 units4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4 filed by Litchev Boyan Vesselinov4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
- SEC Form 4: Newman Michael James sold $100,043 worth of shares (20,000 units at $5.00) as part of a pre-agreed trading plan4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)